Recombinant IL7RA (Lusvertikimab Biosimilar) antibody (PE)
This Humanized Monoclonal antibody specifically detects IL7RA (Lusvertikimab Biosimilar) in FACS. It exhibits reactivity toward Human.
Catalog No. ABIN7867325
$569.23
Plus shipping costs $50.00
100 tests
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for Recombinant IL7RA (Lusvertikimab Biosimilar) antibody (PE) (ABIN7867325)
Target
IL7RA (Lusvertikimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This IL7RA (Lusvertikimab Biosimilar) antibody is conjugated to PE
Application
Flow Cytometry (FACS)
-
-
Purpose
- PE-conjugated Anti-IL7RA(lusvertikimab biosimilar) mAb
-
Isotype
- IgG4
-
-
-
-
Application Notes
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2°C-8°C for 6 months
-
Expiry Date
- 6 months
-
-
- IL7RA (Lusvertikimab Biosimilar)
-
Alternative Name
- lusvertikimab biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms: CD127,CDW127,IL-7R-alpha,IL7RA,ILRA,Effi-7,Effi7-h,MD-707
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P16871
Target
-
You are here:
